With the introduction of Abbott's iDesign Dx system, U.S. ophthalmologists now have a diagnostic tool that can capture five optical measurements in one three-second scan to determine the patient's visual abnormalities. This highly advanced diagnostic tool measures the internal optics and surface of the eye more precisely than conventional methods, allowing doctors to fully evaluate imperfections that result in poor vision. Obtaining these measurements in one three-second scan enables ophthalmologists to screen patients more efficiently to determine if they are eligible for LASIK or other refractive surgery and to assist in diagnosis of other conditions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64467-abbott-idesign-dx-system-available-for-opthalmologists-and-patients
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Mehta Eye Clinic, a leading Eye care specialty clinic in Ghatkopar, Mumbai, has always been on the forefront of technology. With an aspiration to bring the latest and most advanced Eye Care technology for patients, Mehta Eye Clinic has always believed in investing in the best. The Clinic has recently introduced LenSx® -the first of its kind, completely bladeless Laser Assisted Cataract Surgery in the city of Mumbai.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64151-mehta-eye-clinic-laser-cataract-surgery
Start your engines! The Los Angeles Auto Show, the first auto show of the season is here! Widely regarded as being the most forward-thinking of all the major shows, the latest in technology and design exhibited at the show will be finding their way into driveways across the country in the near future. The show proves to be as exciting as ever this year, featuring 22 World debuts, futuristic concept cars, alternative fuel vehicles, and a connected car expo focusing on advanced technologies.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63303-kelley-blue-book-kbb-los-angeles-auto-show-2013-new-cars
Process plants and pipelines generate thousands of alarms from their automation systems every day — many of which are not serious. Control room operators must then quickly distinguish between routine process alarms and critical alarms that warn of operating problems or safety issues.
Honeywell (NYSE:HON) today unveiled its new DynAMo™ Alarm Suite, an advanced alarm management software that reduces the overall number of alarms while helping operators focus and respond to those most critical.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64513-honeywell-new-dynamo-alarm-suite-reduces-nuisance-automation-alarms
The 8th Oxylane Innovation Awards will take place on 18 December, 2013. This is a major event for Oxylane and its Decathlon stores, which place continuous innovation at the heart of their business model.
This year, ten innovations from nine brands will be competing for the awards. These are ingenious technical products suitable for all sports players, from beginners to advanced. These products can be seen as of now, as well as on the awards evening, at the event’s dedicated website: http://oia.oxylane.com.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63480-oxylane-innovation-awards-at-decathlon
Easily create & share stunning diagrams, mindmaps and presentations with Conojo – The 5-In-1 Collaborative Whiteboard App.
Gone are the days of scribbling illegibly on clunky whiteboards, awkwardly passing markers from person to person in order to “work together”. With Conojo, collaborative planning & whiteboarding has never been easier, or quite as much fun.
Conojo’s expansive and versatile toolset has everything you need for sketching, planning, problem solving and teaching. Utilise the intuitive range of drawing tools & pre-made blueprints to quickly visualize and express ideas. Share these brilliant ideas through in-app video recording, or work collaboratively in real time via Bluetooth & Wi-Fi.
Feature List:
* Real-Time Collaborative Whiteboarding
* Easy-to- use Drawing Tools & Shapes
* Huge Variety of Templates Incl. Charts, Graphs, Fishbone diagrams, Flowcharts
* Powerful Bluetooth Integration and Collaboration
* 36 In-built Training Videos for Advanced Features
* 25 Backgrounds and Many Formatting Options
* 100+ Stylish Fonts
* Express Ideas Visually
* Import Any Type of File Seamlessly via Photo Roll, Dropbox, WebDav or more
* Drag and Drop Objects
* Advanced Tools For Dynamic Creations
* Easy Export via Email, Facebook, Twitter, Evernote or more
Conojo is both easy to use, and sufficiently feature-rich. Users Enjoy simple but flexible drawing tools, including but not limited to the pencil, pen, marker, highlighter, and eraser. Create fluid brush strokes in multiple widths and unlimited colours. Once you’ve got the basics covered; take advantage of the 36 in-built training videos to expand your creative range.
Easily collaborate with friends, family or colleagues using Conojo’s powerful sharing capabilities. Join up with fellow Conojo users to narrate whiteboard sessions and share your ideas visually. Alternatively, record and your brainstorming sessions in-app, and export in seconds to YouTube, Social Networks or E-mail.
Conojo is a must have for creative thinkers and compulsive planners alike. Ditch the whiteboard, download Conojo today.
The II Moscow International Forum for Innovative Development “Open Innovations”, which was held in Moscow from October 31 to November 1, 2013, confirmed its role of a global discussion platform in the field of technological innovations.
For two consecutive years now, “Open Innovations” has become the largest event in Russia and one of the biggest events in the world, demonstrating the major trends and key developments in innovative sectors of the economy. Open Innovations Expo 2013, which exposition has become a unique platform for the development and demonstration of advanced technologies, exchange of experience in successful implementing of innovative projects, as well as effective interaction between government, science and business was held within the framework of the Forum.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63505-results-open-innovations-forum-moscow-2013
Texas Instruments (TI) (NASDAQ: TXN) announces the newest additions to the Tiva™ C Series microcontroller (MCU) platform. The Tiva TM4C129x MCUs are the industry’s first ARM® Cortex™-M4-based MCUs with Ethernet MAC+PHY, enabling customers to create a new class of sophisticated, highly connected products that bridge the cloud and amplify the ever-growing Internet of Things (IoT). The feature-rich Tiva TM4C129x MCUs offer an unprecedented number of simultaneous connectivity options, as well as on-chip data protection and LCD controller to save significant board space and enable connected, advanced applications, such as home/building automation gateways, connected human-machine interface (HMI), networked sensor gateways, security access systems, programmable logic controllers and many others.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54050-texas-instruments-tiva-c-series-arm-cortex-m4-ethernet-internet-of-things
HemoCue America, a global leader in advanced point-of-care testing (POCT) systems, announced on October 9, 2013 that the American Red Cross, the world’s largest blood bank organization, has signed a five-year agreement on instruments and consumables for hemoglobin testing of blood donors.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63473-hemocue-red-cross-supply-agreement
In the U.S., approximately 159,000 women are living with metastatic breast cancer. To raise awareness of Metastatic Breast Cancer Awareness Day on October 13, MedImmune Specialty Care Division of AstraZeneca (NYSE: AZN) is launching the My+Story online resource center, which highlights the needs of women living with metastatic breast cancer and calls attention to metastatic disease as a key component of October’s National Breast Cancer Awareness Month. Metastatic Breast Cancer Awareness Day was officially recognized by the U.S. Congress in 2009, following a grassroots awareness effort led by members of the Metastatic Breast Cancer Network (MBCN).
To view Multimedia News Release, go to http://www.multivu.com/mnr/63080-astrazeneca-metastatic-breast-cancer-awareness
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the availability of an extensive set of advanced predictive sciences applications and services. These integrated capabilities enable drug discovery teams to investigate and evaluate hypotheses about the chemical or biological behavior of molecules of therapeutic interest in silico prior to costly experimentation. Accelrys predictive sciences leverages the open, scientifically aware Accelrys Enterprise Platform to deliver an advanced scientific decision support environment that reduces time and expense, improves quality, enhances collaboration and accelerates innovation in bringing new drugs to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62190-accelrys-offers-integrated-predictive-sciences-solutions-faster-innovation
